Patent · US Active

Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same

US9969998B2 · kind B2 · utility

1Cited by
154References
43Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 8, 2016
Grant dateMay 15, 2018
Priority date
Expiry dateMay 14, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are variant adenosine deaminase 2 (ADA2) proteins, conjugates thereof and compositions containing the proteins and/or conjugates. Also provided are methods and uses of the ADA2 proteins or conjugates for treating diseases and conditions, such as a tumor or cancer, and in particular any disease or condition associated with elevated adenosine or other associated marker.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.